You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仙琚製藥(002332.SZ):放棄參股公司萃澤醫藥增資擴股優先認繳出資權

格隆匯6月25日丨仙琚製藥(002332.SZ)公佈,浙江萃澤醫藥科技有限公司(以下簡稱“萃澤醫藥”)系浙江仙琚製藥股份有限公司(以下簡稱“公司”)的參股公司,公司持有其37.3879%的股權。近日,公司收到萃澤醫藥擬增加註冊資本的通知,考慮到經營需求,萃澤醫藥註冊資本擬由1529.0243萬元增資到1618.0152萬元,擬增加註冊資本88.9909萬元,增資價格爲37.0825元/股。公司結合實際經營情況,擬放棄本次股權增資的優先認繳出資權。

本次增資擬由以下5家投資方參與:仙居縣海納包裝有限公司出資1200萬元人民幣,王煥勇出資900萬元人民幣,王寶軍出資600萬元人民幣,鄭旭芬出資300萬元人民幣,樓曉炯出資300萬元人民幣。擬參與增資的5家認購方以現金出資合計3300萬元人民幣,認購萃澤醫藥的新增註冊資本88.9909萬元。本次增資完成後,公司持有萃澤醫藥的股權比例由原來的37.3879%降至35.3316%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account